Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone/Formoterol vs Ultibro in ACOS
NCT02693769Phase 3Terminated
- Sponsor
- Mundipharma
- Start
- Jul 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate, formoterol in asthma chronic obstructive pulmonary disease overlap syndrome (ACOS), sponsored by Mundipharma. Started Jul 2016; status: terminated.
02
Drugs
fluticasone propionateformoterol
03
Conditions
asthma chronic obstructive pulmonary disease overlap syndrome (ACOS)
Beyond the preview
Go deeper on NCT02693769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02693769.